Wilson LM, Donahoe JT, Herzig SJ, Anderson TS. Industry Payments to Physicians During Medical Specialty Society Conferences. J GEN INTERN MED. Published online January 2, 2025. doi:10.1007/s11606-024-09269-6

Persaud S, Al Hadidi S, Anderson TS, Gallagher G, Chimonas S, Korenstein D, Mitchell A. Industry Payments to Physicians Endorsing Drugs and Devices on a Social Media Platform. JAMA. 2024;331(24):2131–2134. doi:10.1001/jama.2024.7832

Dhruva SS, Ross JS, Steinman MA, Gan S, Muluk S, Anderson TS. Intravascular Microaxial Left Ventricular Assist Device Manufacturer Payments to Cardiologists and Use of Devices. JAMA. Published online April 10, 2024. doi:10.1001/jama.2024.4682

Uppal N, Anderson TS. Association Between Pharmaceutical Industry Marketing Payments to Physicians and Intra-articular Hyaluronic Acid Administration to Medicare Beneficiaries. JAMA Intern Med. Published online March 20, 2023

Zhang AD, Anderson TS. Comparison of Industry Payments to Physicians and Advanced Practice Clinicians. JAMA. Published online October 31, 2022.

Uppal N, Anderson TS. Changes in Industry Marketing and Research Payments to US Physicians and Teaching Hospitals During the COVID-19 Pandemic. JAMA Health Forum. 2022;3(9):e223342.

Uppal N, Anderson TS. Learning from the Opioid Epidemic: Preventing the Next Healthcare Marketing Crisis. J Gen Intern Med. 2021 11; 36(11):3553-3556

Jiang S, Anderson TS, Marcum ZA. Patterns of Pharmaceutical Industry Marketing to Physicians for Direct-Acting Antivirals, 2013 Through 2019. Ann Pharmacother. 2022 02; 56(2):229-231

Anderson TS, Gellad WF, Good CB. Characteristics Of Biomedical Industry Payments To Teaching Hospitals. Health Aff (Millwood). 2020 Sep;39(9):1583-1591. doi: 10.1377/hlthaff.2020.00385. PMID: 32897778.

Hadland SE, Cerdá M, Earlywine JJ, Krieger MS, Anderson TS, Marshall BDL. Analysis of Pharmaceutical Industry Marketing of Stimulants, 2014 Through 2018. JAMA Pediatr. 2020 04 01; 174(4):385-387

Anderson TS, DeJong C, Good CB, Gellad WF. Disclosure of Article Funding and Conflicts of Interest in High-Impact Clinical Journals. J Gen Intern Med. 2020 04; 35(4):1345-1347.

Anderson TS, Krieger MS, Marshall BDL, Cerdá M, Hadland S. Financial Payments to Teaching Hospitals by Companies Marketing Opioids. J Gen Intern Med. 2020 10; 35(10):3108-3110

Anderson TS, Good CB, Gellad WF. Industry Payments to Academic Physicians: a Comparison of Reporting to Two Government Agencies. J Gen Intern Med. 2018 10; 33(10):1604-1606

Anderson TS, Good CB, Gellad WF. Prevalence and compensation of academic leaders, professors, and trustees on publicly traded US healthcare company boards of directors: cross sectional study. BMJ. 2015 Sep 29;351:h4826.

Anderson TS, Huskamp HA, Epstein AJ, Barry CL, Men A, Berndt ER, Horvitz-Lennon M, Normand SL, Donohue JM. Antipsychotic prescribing: do conflict of interest policies make a difference? Med Care. 2015 Apr; 53(4):338-45.

Anderson TS, Dave S, Good CB, Gellad WF. Academic medical center leadership on pharmaceutical company boards of directors. JAMA. 2014 Apr 02; 311(13):1353-5

Publications from our team: